AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported financial ...
Quarterly revenue of $935 million, above the midpoint of guidance Quarterly GAAP net income of $90 million and net income per diluted share of $1.33Quarterly Adjusted EBITDA of $237 million and Non-GA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results